Leading Experts To Present New Innovations In Dermatology At 2013 North American Veterinary Conference
ORLANDO, Fla. – Jan. 20, 2013 – Recognized specialists in veterinary medicine will lead a series of educational programs on current advancements in dermatology during the North American Veterinary Conference in Orlando. The series, sponsored by Pfizer Animal Health, begins with a symposium, “Excellence in Dermatology: New Tools for Your Kit,” at 1:45 p.m. on Sunday, Jan. 20. The symposium will feature two sessions: Mark Papich, DVM, MS, DACVCP, will discuss “Where to Place Your Bets: Winning Strategies for Treating Resistant Skin Infections;” Valerie Fadok, DVM, PhD, DACVD, and Dana Liska, DVM, DACVD, will team-teach the session “Target the Itch: The Latest What-Ifs and How-Tos.”
Dr. Papich will look at the challenges of resistant skin infections and which drug is right for which patient. Then, Drs. Fadok and Liska will use audience-response selection of case reviews and summarize the newest treatment strategies and the inevitable roadblocks dermatology patients present.
“One of the biggest challenges facing veterinarians when treating dermatology cases is identifying and treating resistant skin infections,” said Candace Sousa, DVM, DABVP, DACVD, a dermatologist and associate director of veterinary operations with Zoetis. “Sometimes, it is necessary to venture into uncharted territory to choose the right treatment to find success. We are pleased to have these leading specialists provide their expertise for this symposium.”
Two recurring educational sessions will be presented at the Education Center located at the Zoetis booth (#1819) in the Gaylord Palms Exhibit Hall.
New Science Presented in a New Way
Beginning on Sunday, Jan. 20, and continuing through Wednesday, Jan. 23, Michele Rosenbaum, VMD, DACVD, and Dr. Sousa will present new findings in “Pathophysiology of Canine Allergic Disease.” This interactive, case-based session will discuss new targets for treatment of pruritic conditions in dogs and the pathophysiology of canine allergic disease. For the first time at NAVC, this program will be presented using ViSTa, an innovative, 3D virtual world that allows veterinarians to earn CE credit while learning about breakthrough science in canine allergic disease from their homes or offices, anywhere in the world. The session will be presented hourly in the Zoetis booth each day from 9 a.m. until 5 p.m.
On Monday, Jan. 21, Dr. Fadok will present three 30-minute sessions at 9:30 a.m., noon and 1 p.m. on “New Targets for Treatment of Pruritic Skin Conditions in Dogs.” She will address the challenges of existing treatments in controlling the itch associated with allergic skin disease, how cytokines perpetuate the vicious cycle of itch and inflammation, and how this discovery could change the way allergic dogs are treated.
Zoetis, a business unit of Zoetis Inc., is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. For more than 60 years, we have been committed to enhancing the health of animals and bringing solutions to our customers who raise and care for them. To learn more, visit www.pfizeranimalhealth.com.
For further information, Contact:
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States